MV BioTherapeutics

usitransfer-usi_transfer_-_img_mv_biotherapeutics.jpeg

MV BioTherapeutics is a spin-off of the Institute for Research in Biomedicine (IRB, affiliated to USI) which was established in 2018, originally as MicroVaccines and later renamed MV BioTherapeutics. Its founder, Dr. Fabio Grassi (researcher and group leader at the IRB), has developed an innovative technology platform for the development of oral vaccines against intestinal infections, with the aim of addressing currently unresolved medical needs with high patient accessibility. In 2017, Grassi took the initial project, called EXEAD, to the then StartCup Ticino (now Boldbrain), coming in second in the finals. Since then, Fabio Grassi has incubated his startup at USI Startup Centre.

 

MV BioTherapeutics - homepage

Events
08
October
2022
08.
10.
2022

Bellinzona Research Institutes Open Day

Faculty of Biomedical Sciences

The violence we do not see

Faculty of Communication, Culture and Society, Faculty of Economics
10
October
2022
10.
10.
2022

Poeti del Novecento

Faculty of Communication, Culture and Society